NEW YORK — Belgian molecular diagnostics firm OncoDNA said on Friday that it has closed a €19 million ($20.6 million) Series B financing round.
The round was led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank. Other participants included SFPI-FPIM, CPH Bank, Inventures, Sambrinvest, Sofinim, SRIW, and undisclosed existing investors.